At 243.9x earnings and 76.7x forward earnings, this stock is priced for a growth profile that simply does not exist in the data. EPS collapses to $0.08 next year despite a current EPS of 12.5, yet the market still assigns a premium multiple, and the absence of a PEG only reinforces the lack of visible growth justification. The Altman Z-Score of 1.1 signals financial stress risk, not stability, and with operating margins at just 0.50%, this is a structurally thin business trading at an aggressive valuation. This is not a mispricing in favor of value investors — it looks like a yield-driven name being priced beyond its underlying profitability and balance sheet strength.